The vector of anti-PSCA chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human PSCA. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-PSCA antibody linked to CD3ζ signaling domains. And the vector product was designed for the treatment of Prostate cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-T-1-L347-G||Anti-PSCA scFv h(FcεRIγ) CART, pCDCAR1|
|CAR-MZ038||Anti-PSCA (Ha1-4.117 ) h(CD3ζ) CAR, pCDCAR1|
|CAR-T-2-L347-4Z||Anti-PSCA scFv h(CD4-CD3ζ) CART, pCDCAR1|
|CAR-T-2-L347-CZ||Anti-PSCA scFv h(b2c-CD3ζ) CART, pCDCAR1|
|CAR-T-3-L347-2XZ||Anti-PSCA scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC852||Lenti-PSCA CAR (scFv-CD28-CD3ζ, 7F5) Viral Particle|
|VP-CAR-LC758||Lenti-PSCA CAR (scFv-CD28-41BB-CD3ζ, bm2B3) Viral Particle|
|CAR-T-1-L347-2||Anti-PSCA scFv h(CD28) CART, pCDCAR1|
|CAR-MZ039||Anti-PSCA (Ha1-4.117 ) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-T-1-L347-Z||Anti-PSCA scFv h(CD3ζ) CART, pCDCAR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved